Home Digestive Disorders IBD: Crohn’s Disease What’s Health Canada Saying about Biosimilars?

IBD: Crohn's Disease

What’s Health Canada Saying about Biosimilars?

Tags: ,

A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!

This video was made possible by an unrestricted educational grant by Pfizer Canada. 

Related Articles

Living with Crohn’s Disease Infographic
Living with Crohn’s Disease Infographic

Tags:

Read More

Inflammatory Bowel Disease with Dr. Mike Evans

Tags:

Read More

The Timeline of My UC Diagnosis

Tags:

Read More

What’s Health Canada Saying about Biosimilars?

[embed]https://www.youtube.com/watch?v=1OeDtXWn3_8[/embed]
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!